108379-95-9

Upstream product

• 53937-02-3 4-(benzyloxy)pyridin-2(1H)-one 
• 626-03-9 3-deazauracil 
• 100-39-0 benzyl bromide 

Downstream Products

• 108379-97-1 2-benzyl-5-benzyloxy-2-azabicyclo<2.2.0>hex-5-en-3-one 
• 571168-92-8 1-benzyl-4-benzyloxy-3-iodopyridin-2(1H)-one 
• 108380-01-4 2-benzyl-2-azabicyclo<2.2.0>hexane-3,5-dione 
• 586373-19-5 1-benzyl-4-hydroxypyridin-2(1H)-one 
• 586373-15-1 1-benzyl-4-(benzyloxy)-3-ethylpyridin-2(1H)-one 

Relevant academic research and scientific papers

Practical Pd/C-catalysed suzuki-miyaura reactions for the preparation of 3-aryl-4-oxypyridin-2(1H)-ones, 3-aryl-2,4-oxypyridines and 3-aryl-2,4- oxyquinolines as useful intermediates for the synthesis of biologically active compounds

Practical heterogeneous Pd/C-catalysed Suzuki-Miyaura cross-coupling reactions of 3-iodo-4-oxypyridin-2(1H)-ones, 3-iodo-2,4-oxypyridines, and 3-iodo-2,4-oxyquinolines with arylboronic acids are described as a useful and efficient alternative to homogeneous conditions. The methodology features ligand-free and environmentally friendly conditions, and tolerates a wide range of boronic acids. The cross-coupled products can be viewed as useful intermediates for the preparation of 3-aryl-4-hydroxypyridin-2(1H)-ones, which can be used as new nucleobases for antiherpetic agents.

SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE

The present application relates to novel substituted bicyclic heteroaryl compounds, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or proph

Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase

The identification and evolution of a series of potent and selective p38 inhibitors is described. p38 inhibitors based on a N-benzyl pyridinone high-throughput screening hit were prepared and their SAR explored. Their design was guided by ligand bound co-

Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase

Enoyl-ACP reductase (ENR), the product of the FabI gene, from Bacillus anthracis (BaENR) is responsible for catalyzing the final step of bacterial fatty acid biosynthesis. A number of novel 2-pyridone derivatives were synthesized and shown to be potent inhibitors of BaENR.

FAB I INHIBITOR AND PROCESS FOR PREPARING SAME

A compound which is effective for inhibiting Fab I, and a method for treating a bacterial infection.

Furanopyridine derivatives and methods of use

The present invention relates to furanopyridine compounds having the general Formula I: and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical composition

A practical procedure for the selective N-alkylation of 4-alkoxy-2-pyridones and its use in a sulfone-mediated synthesis of N-methyl-4-methoxy-2-pyridone

It has been found that selective N-alkylation of 4-alkoxy-2-pyridones can be achieved under anhydrous, mild conditions with tetrabutylammonium iodide and potassium tert-butoxide being employed as the catalyst and the base, respectively. The procedure was applied to the preparation of 4-methoxy-1-methyl-2-pyridone, a valuable building block for heterocycle synthesis.

Cycloadditions in Syntheses. Part 28. 2-Azabicyclohexane-3,5-dione and its Derivatives: Synthesis and Transformation to Azetidin-2-ones

2-Azabicyclohexane-3,5-dione has been synthesized via photopyridone formation from 4-(dimethyl-t-butylsiloxy)- or 4-alkoxy-2-pyridones followed by mild acid hydrolysis.The title compound and its derivatives react with a variety of nucleophiles (ROH